Validation of aortic valve calcium quantification thresholds measured by computed tomography in Asian patients with calcific aortic stenosis.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
18 04 2022
Historique:
received: 27 12 2020
accepted: 20 05 2021
pubmed: 27 6 2021
medline: 21 4 2022
entrez: 26 6 2021
Statut: ppublish

Résumé

Sex-specific thresholds of aortic valve calcification (AVC) have been proposed and validated in Caucasians. Thus, we aimed to validate their accuracy in Asians. Patients with calcific aortic stenosis (AS) from seven international centres were included. Exclusion criteria were ≥moderate aortic/mitral regurgitation and bicuspid valve. Optimal AVC and AVC-density sex-specific thresholds for severe AS were obtained in concordant grading and normal flow patients (CG/NF). We included 1263 patients [728 (57%) Asians, 573 (45%) women, 837 (66%) with CG/NF]. Mean gradient was 48 (26-64) mmHg and peak aortic velocity 4.5 (3.4-5.1) m/s. Optimal AVC thresholds were: 2145 Agatston Units (AU) in men and 1301 AU in women for Asians; and 1885 AU in men and 1129 AU in women for Caucasians. Overall, accuracy (% correctly classified) was high and comparable either using optimal or guidelines' thresholds (2000 AU in men, 1200 AU in women). However, accuracy was lower in Asian women vs. Caucasian women (76-78% vs. 94-95%; P < 0.001). Accuracy of AVC-density (476 AU/cm2 in men and 292 AU/cm2 in women) was comparable to absolute AVC in Caucasians (91% vs. 91%, respectively, P = 0.74), but higher than absolute AVC in Asians (87% vs. 81%, P < 0.001). There was no interaction between AVC/AVC-density and ethnicity (all P > 0.41) with regards to AS haemodynamic severity. AVC thresholds defining severe AS are comparable in Asian and Caucasian populations, and similar to those proposed in the guidelines. However, accuracy of AVC to identify severe AS in Asians (especially women) is sub-optimal. Therefore, the use of AVC-density is preferable in Asians.

Identifiants

pubmed: 34172988
pii: 6309722
doi: 10.1093/ehjci/jeab116
pmc: PMC9016361
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-726

Subventions

Organisme : Quebec Heart &amp; Lung Institute Foundation
Organisme : Biomedical Research 2015
ID : 15/JTA
Organisme : Canada Research Chair in Valvular Heart Diseases and a Foundation Scheme Grant
ID : FDN-143225
Organisme : Heart and Stroke Foundation
ID : NNI-2019-2020
Organisme : CIHR
ID : EIA-CFBA-179680
Pays : Canada
Organisme : British Heart Foundation
ID : FS/14/78/31020
Pays : United Kingdom
Organisme : Sir Jules Thorn Award for Biomedical Research 2015 (15/JTA)
Organisme : Canadian Institutes of Health Research)
Organisme : New National Investigator award from the Heart and Stroke Foundation
ID : NNI-2019-2020
Organisme : CIHR
ID : EIA-CFBA-179680
Pays : Canada

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

JACC Cardiovasc Imaging. 2020 Dec;13(12):2678-2680
pubmed: 32739368
J Am Coll Cardiol. 2014 Sep 23;64(12):1202-13
pubmed: 25236511
J Am Coll Cardiol. 2020 Apr 28;75(16):1897-1909
pubmed: 32327100
Atherosclerosis. 2008 May;198(1):104-14
pubmed: 17950742
Singapore Med J. 2018 Sep;59(9):452-454
pubmed: 30128576
JACC Cardiovasc Interv. 2020 Jan 27;13(2):149-156
pubmed: 31973792
J Am Soc Echocardiogr. 2020 Aug;33(8):953-963.e5
pubmed: 32580897
Catheter Cardiovasc Interv. 2015 Mar;85 Suppl 1:752-61
pubmed: 25630494
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14
pubmed: 25559473
J Cardiol. 2015 Feb;65(2):112-6
pubmed: 24927855
JACC Cardiovasc Imaging. 2019 Jan;12(1):1-24
pubmed: 30621986
JACC Cardiovasc Imaging. 2017 Feb;10(2):185-202
pubmed: 28183438
Eur Heart J. 2017 Sep 21;38(36):2739-2791
pubmed: 28886619
J Am Heart Assoc. 2020 May 18;9(10):e015610
pubmed: 32384012
Circ Res. 2017 Feb 17;120(4):681-691
pubmed: 27879282
Circ Cardiovasc Imaging. 2018 Mar;11(3):e007146
pubmed: 29555836
Cardiol Clin. 2020 Feb;38(1):129-138
pubmed: 31753171
JACC Cardiovasc Imaging. 2020 Mar;13(3):699-711
pubmed: 31422128
J Am Soc Echocardiogr. 2017 Apr;30(4):372-392
pubmed: 28385280
J Am Soc Echocardiogr. 2017 Oct;30(10):1038-1041
pubmed: 28764864
JACC Cardiovasc Imaging. 2019 Sep;12(9):1835-1848
pubmed: 31488252
J Am Coll Cardiol. 2017 Apr 25;69(16):2096-2098
pubmed: 28427584
JACC Cardiovasc Imaging. 2016 Jul;9(7):797-805
pubmed: 27209111

Auteurs

Ezequiel Guzzetti (E)

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, Quebec G1V-4G5, Canada.

Jin Kyung Oh (JK)

Division of Cardiology, Department of Internal Medicine, Chungnam National University Sejong Hospital, Chungnam National University College of Medicine, Sejong 30099, Korea.

Mylène Shen (M)

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, Quebec G1V-4G5, Canada.

Marc R Dweck (MR)

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Kian Keong Poh (KK)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore 119074, Singapore.
Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.

Amr E Abbas (AE)

Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak, Royal Oak, MI 48073, USA.

Ramy Mando (R)

Department of Cardiovascular Medicine, Beaumont Hospital Royal Oak, Royal Oak, MI 48073, USA.

Gregg S Pressman (GS)

Division of Cardiology, Einstein Medical Center, Philadelphia, PA 19141, USA.

Daniel Brito (D)

Division of Cardiology, Einstein Medical Center, Philadelphia, PA 19141, USA.

Lionel Tastet (L)

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, Quebec G1V-4G5, Canada.

Tania Pawade (T)

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.

Mariano Luis Falconi (ML)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.

Diego Perez de Arenaza (DP)

Department of Cardiology, Hospital Italiano de Buenos Aires, Buenos Aires C1199, Argentina.

William Kong (W)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore 119074, Singapore.

Edgar Tay (E)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore 119074, Singapore.

Philippe Pibarot (P)

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, Quebec G1V-4G5, Canada.

Jae-Kwan Song (JK)

Valvular Heart Disease Center, Asan Medical Center Heart Institute, University of Ulsan College of Medicine, Seoul 138736, Korea.

Marie-Annick Clavel (MA)

Institut Universitaire de Cardiologie et de Pneumologie de Québec/Quebec Heart & Lung Institute, Laval University, 2725 Chemin Sainte-Foy, Quebec City, Quebec G1V-4G5, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH